Dernières nouvelles pour Destiny Tech100 (NYSE:DXYZ) Stock

Destiny Tech100 Inc is a non-diversified, closed-end management investment company. It invests in a portfolio of what is believed to be 100 of the top venture-backed private technology companies.

Destiny Tech100 Inc

News

Guidance

Brunswick Lowers FY2025 Adj EPS Guidance from $3.50-$5.00 to $2.50-$4.00 vs $3.93 Est; Lowers FY2025 Sales Guidance from $5.20B-$5.60B to $5.00B-$5.40B vs $5.28B Est

TransUnion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRU#NYSE">TRU</a>) affirms FY2025 Adj EPS guidance from $3.93-$4.08 to $3.93-$4.08 vs $4.07 analyst estimate. Raises FY2025 sales outlook from $4.33 billion-$4.39 billion to $4.36 billion-$4.42 billion vs $4.38 billion estimate.

TransUnion Affirms FY2025 Adj EPS Guidance of $3.93-$4.08 vs $4.07 Est; Raises FY2025 Sales Guidance from $4.33B-$4.39B to $4.36B-$4.42B vs $4.38B Est

TransUnion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRU#NYSE">TRU</a>) raises FY2025 GAAP EPS guidance from $1.68-$1.82 to $1.92-$2.06 vs $2.44 analyst estimate..

TransUnion Raises FY2025 GAAP EPS Guidance from $1.68-$1.82 to $1.92-$2.06 vs $2.44 Est

TransUnion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRU#NYSE">TRU</a>) is looking for Q2 GAAP EPS of $0.35-$0.39 vs $0.63 analyst estimate..

TransUnion Sees Q2 GAAP EPS $0.35-$0.39 vs $0.63 Est

Dassault Systemes (OTC:<a class="ticker" href="https://www.benzinga.com/stock/DASTY#OTC">DASTY</a>) .

DASTY

Dassault Systemes FY25 objectives unchanged, Total revenue growth of 6-8% and diluted EPS of €1.36-€1.39.

TransUnion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRU#NYSE">TRU</a>) is looking for Q2 Adj EPS of $0.95-$0.99 vs $1.02 analyst estimate. sees sales of $1.076 billion-$1.095 billion vs $1.10 billion analyst estimate.

TransUnion Sees Q2 Adj EPS $0.95-$0.99 vs $1.02 Est; Sees Sales $1.076B-$1.095B vs $1.10B Est

Dassault Systemes (OTC:<a class="ticker" href="https://www.benzinga.com/stock/DASTY#OTC">DASTY</a>) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.32 by 6.25 percent. This is a 3.03 percent increase over earnings of $0.33 per share from the same period last year. The company reported quarterly sales of $1.65 billion which beat the analyst consensus estimate of $1.59 billion by 3.70 percent. This is a 1.53 percent increase over sales of $1.63 billion the same period last year.

Earnings

Earnings Beats

Dassault Systemes Q1 Adj. EPS $0.34 Beats $0.32 Estimate, Sales $1.65B Beat $1.59B Estimate

TransUnion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRU#NYSE">TRU</a>) reported quarterly earnings of $1.05 per share which beat the analyst consensus estimate of $0.97 by 8.25 percent. This is a 14.13 percent increase over earnings of $0.92 per share from the same period last year. The company reported quarterly sales of $1.10 billion which beat the analyst consensus estimate of $1.07 billion by 2.29 percent. This is a 7.35 percent increase over sales of $1.02 billion the same period last year.

TransUnion Q1 Adj. EPS $1.05 Beats $0.97 Estimate, Sales $1.10B Beat $1.07B Estimate

Brunswick Q1 2025 Adj. EPS $0.56 May Not Be Comparable To $0.23 Estimate, Sales $1.22B Beat $1.13B Estimate

Stephens &amp; Co. analyst Jim Salera reiterates First Watch Restaurant Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWRG#NASDAQ">FWRG</a>) with a Overweight and maintains $24 price target.

Price Target

Reiteration

Analyst Ratings

FWRG

Stephens & Co. Reiterates Overweight on First Watch Restaurant Gr, Maintains $24 Price Target

An SEC filing made by Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) says that protests against the brand, as well as CEO Elon Musk, are a risk factor for the EV giant.
What Happened: In a quarterly report filed with the SEC on Wednesday, the company outlines that exaggerated or unfounded criticism of the company's management team by third parties can make it difficult for the company to raise funds.
"Tesla and its management are subject to significant amounts of commentary by a range of third parties. Such attention can include criticism, which may be exaggerated or unfounded, such as speculation regarding the sufficiency or stability of our management team, and has incited protests, some escalating to violence targeting our operations, products and personnel." The filing states.
The addition of protests and violence wasn't included in earlier filings, signalling a shift in legal language by the company as it officially recognizes the protests as a risk factor.
Why It Matters: The updated position in the filing comes in as Tesla reels from the effects of <a href="https://www.benzinga.com/25/03/44394560/elon-musks-tesla-targeted-with-arson-attacks-in-las-vegas-kansas-city-report">protests as well as vandalism </a>against the company and its properties, largely due to Musk's involvement in U.S. President Donald Trump&#8216;s administration and DOGE.
U.S. Attorney General Pam Bondi had earlier claimed that the <a href="https://www.benzinga.com/tech/25/04/44706944/elon-musk-warns-those-who-financed-tesla-attacks-will-go-to-prison">attacks on Tesla properties</a> were an act of "domestic terrorism," as she announced the DoJ will be seeking a 20-year sentence for one of the accused, who allegedly threw a pipe bomb at a Tesla dealership in Colorado.
Elsewhere, in the earnings call with investors on Tuesday evening, Musk claimed that the protests were <a href="https://www.benzinga.com/25/04/44942774/elon-musk-slams-tesla-protesters-says-they-benefited-from-government-waste-and-fraud-he-believes-to-have-cut-via-doge-theyre-the-recipients-of-wasteful-largesse">funded by government waste</a> and fraud. "The actual reason is that the the is that those receiving the waste and fraud wish to continue receiving it," Musk said.
However, Tesla owners in the U.S. <a href="https://www.benzinga.com/trading-ideas/25/04/44829030/tesla-owners-face-new-challenge-amid-tariffs-vandalism-insurance-costs-going-up-twice-the-national-rate">continue to face troubles </a>as insurance costs for their vehicles have experienced a surge owing to increased vandalism and declining used car value, among other reasons.
Check out more of Benzinga's Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44971783/piper-sandler-puts-400-price-target-on-tesla-it-appears-our-best-case-scenario-has-materialized">Piper Sandler Puts $400 Price Target On Tesla: &#8216;It Appears Our Best-Case Scenario Has Materialized&#8217;</a></li>
</ul>
Image Via Shutterstock

Politics

Tech

General

TSLA

Tesla Protests Are Now An Official Risk Factor For Elon Musk's EV Giant: Company Tells SEC 'Exaggerated' Criticism Could Hinder Fundraising Efforts

By extending their partnership, Redis and UiPath will explore ways to leverage the Redis vector database, Semantic Caching, and Semantic Routing to support <a href="https://www.globenewswire.com/Tracker?data=367r1UrsY_x6VbumJW97L0aBJwkjDn_Hs9m2YDd6_c892FYpUFx6-mURL6ZiXQs0rajK9eHx-r6mKR39o_fxkn_8zWi7r-dN7n985BgmWup6kZV8SX-wltRC3hSYZRQp">UiPath Agent Builder</a>, a secure, simple way to build, test, and launch agents and the agentic automations they are executing. With Redis powering these solutions, UiPath agents will understand the meaning behind user queries, making data access faster and system responses smarter, which delivers greater speed and cost efficiency to enterprise developers looking to take advantage of automation. Additionally, via the utilization of semantic routing, UiPath agents will be able to leverage the best LLM or LLM provider depending on the context, intent, and use-case which the customer is trying to solve.

Contracts

PATH

Redis And UiPath Have Expanded Their Collaboration Toward Furthering Agentic Automation Solutions For Customers

Needham analyst Ryan MacDonald reiterates Tempus AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>) with a Buy and maintains $70 price target.

Needham Reiterates Buy on Tempus AI, Maintains $70 Price Target

West Pharmaceutical Services, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WST#NYSE">WST</a>), a global leader in innovative solutions for injectable drug administration, today announced executive leadership changes as part of its succession planning process.
&nbsp;
<ul>
<li>Bernard J. Birkett, Senior Vice President, Chief Financial Officer, informed West of his intention to step down from his current position this year. West has commenced a search for a successor. Mr. Birkett and West plan for him to remain as CFO until his successor is in place, and as an advisor to West in order to facilitate a seamless transition. &nbsp;</li>
<li>Shane Campbell has been appointed to serve as Senior Vice President, Chief Proprietary Segment Officer, effective May 5, 2025.</li>
</ul>
CFO Transition&nbsp;
"On behalf of all of us at West, I want to thank Bernard for his strong contributions and leadership over the past seven years. He has been an invaluable partner and advisor to me and the entire leadership team," said Eric M. Green, President, Chief Executive Officer and Chair of the Board. "Bernard played a critical role along with the Finance and Global Operations teams, in helping West navigate the challenges of the global pandemic, the complexities of destocking, and the emergence of GLP-1s. He has been instrumental in our continued growth, and I look forward to his support as we search for his successor."
"After great consideration, I have decided to bring my tenure at West to a close in order to pursue new endeavors. It has been an honor to serve as the CFO of West, making a positive difference on patients' lives," Mr. Birkett said. "West has exceptional people, and I want to thank our talented team for all that we have accomplished together."
Mr. Birkett joined West as Senior Vice President and Chief Financial Officer in June 2018. In 2022, he was appointed to the combined role of Chief Financial and Operations Officer. In April 2024, he transitioned back to focusing solely on his responsibilities as Chief Financial Officer. Mr. Birkett's contributions have been pivotal in strengthening West's financial and business profile.
Chief Proprietary Segment Officer Appointment
Mr. Campbell joins West from Carlisle Companies Inc., where he served as Chief Commercial Officer of the Construction Materials business. As an accomplished leader, Mr. Campbell brings extensive global management experience across operations, engineering, commercial and strategy. Over a 20-year career at DuPont, Mr. Campbell served in a number of senior global leadership roles focused in the areas of elastomers, polymers, building materials, chemicals, packaging and safety.
"We are thrilled to welcome Shane to our team at West," said Mr. Green. "His extensive industry experience and strategic vision will be invaluable as we continue to drive our Proprietary Products strategy and ensure West achieves its long-term growth and success."
"I am excited to join West and work alongside such a talented team that is dedicated to improving patient health," said Mr. Campbell. "With a legacy of over a century of innovation, West is well-positioned to sustain its success well into the future, and I look forward to contributing to the tradition of excellence that pervades the Company."

Management

West Pharma CFO Bernard Birkett to Exit in 2025, Successor Search Underway for Seamless Transition

Outlook for the Second Quarter 2025
For the second quarter ending June 30, 2025, FARO currently expects:
<ul>
<li>Revenue in the range of $79 to $87 million</li>
<li>Gross margin in the range of 56.5% to 58.0%. Non-GAAP gross margin in the range of 57.0% to 58.5%</li>
<li>Operating expenses in the range of $45.0 to $47.0 million. Non-GAAP operating expenses in the range of $38.5 to $40.5 million</li>
<li>Net (loss) income per share in the range of ($0.20) to $0.00. Non-GAAP net income per share in the range of $0.20 to $0.40.</li>
</ul>

FARO

Faro Technologies Sees Q2 2025 Adj EPS $0.20-$0.40 vs $0.20 Est; Sees Sales $79M-$87M vs $82.83M Est

PG&amp;E (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PCG#NYSE">PCG</a>) affirms FY2025 Adj EPS guidance from $1.48-$1.52 to $1.48-$1.52 vs $1.50 analyst estimate..

PG&E Affirms FY2025 Adj EPS Guidance of $1.48-$1.52 vs $1.50 Est

PG&amp;E (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PCG#NYSE">PCG</a>) lowers FY2025 GAAP EPS guidance from $1.30-$1.36 to $1.29-$1.35 vs $1.44 analyst estimate..

PG&E Lowers FY2025 GAAP EPS Guidance from $1.30-$1.36 to $1.29-$1.35 vs $1.44 Est

Xcel Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XEL#NASDAQ">XEL</a>) reported quarterly earnings of $0.84 per share which missed the analyst consensus estimate of $0.92 by 8.7 percent. This is a 4.55 percent decrease over earnings of $0.88 per share from the same period last year. The company reported quarterly sales of $3.91 billion which missed the analyst consensus estimate of $3.93 billion by 0.67 percent. This is a 7.04 percent increase over sales of $3.65 billion the same period last year.

Earnings Misses

Xcel Energy Q1 Adj. EPS $0.84 Misses $0.92 Estimate, Sales $3.91B Miss $3.93B Estimate

Faro Technologies Q1 2025 Adj. EPS $0.33 May Not Be Comparable To $0.16 Estimate, Sales $82.86M Beat $80.25M Estimate

WIIM

PepsiCo shares are trading lower after the company reported mixed Q1 results and issued FY25 EPS guidance below estimates. The company indicated it sees more volatility and uncertainty related to trade, which it expects to increase supply chain costs.

Comments

Destiny Tech100

Actualités

Dernières nouvelles pour Destiny Tech100 (NYSE:DXYZ) Stock

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL